518 related articles for article (PubMed ID: 26304878)
1. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.
Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL
J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878
[TBL] [Abstract][Full Text] [Related]
2. Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer.
Lin CC; Bruinooge SS; Kirkwood MK; Hershman DL; Jemal A; Guadagnolo BA; Yu JB; Hopkins S; Goldstein M; Bajorin D; Giordano SH; Kosty M; Arnone A; Hanley A; Stevens S; Olsen C
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):719-28. PubMed ID: 26972644
[TBL] [Abstract][Full Text] [Related]
3. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
[TBL] [Abstract][Full Text] [Related]
4. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
5. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
Panchal JM; Lairson DR; Chan W; Du XL
Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
[TBL] [Abstract][Full Text] [Related]
6. Association between travel distance and metastatic disease at diagnosis among patients with colon cancer.
Massarweh NN; Chiang YJ; Xing Y; Chang GJ; Haynes AB; You YN; Feig BW; Cormier JN
J Clin Oncol; 2014 Mar; 32(9):942-8. PubMed ID: 24516014
[TBL] [Abstract][Full Text] [Related]
7. Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients.
Weeks KS; Lynch CF; West M; Carnahan R; O'Rorke M; Oleson J; McDonald M; Stewart SL; ; Charlton M
Gynecol Oncol; 2022 Jan; 164(1):3-11. PubMed ID: 34776243
[TBL] [Abstract][Full Text] [Related]
8. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
9. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.
Murphy CC; Harlan LC; Warren JL; Geiger AM
J Clin Oncol; 2015 Aug; 33(23):2530-6. PubMed ID: 26150445
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer surgery in Arizona: a statewide analysis of access to care.
Benjamin I; Dalton H; Qiu Y; Cayco L; Johnson WG; Balducci J
Gynecol Oncol; 2011 Apr; 121(1):83-6. PubMed ID: 21208650
[TBL] [Abstract][Full Text] [Related]
11. Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States.
Hao S; Snyder RA; Irish W; Parikh AA
PLoS Med; 2021 Oct; 18(10):e1003842. PubMed ID: 34695123
[TBL] [Abstract][Full Text] [Related]
12. Association between the availability of medical oncologists and initiation of chemotherapy for patients with stage III colon cancer.
Lin CC; Virgo KS
J Oncol Pract; 2013 Jan; 9(1):27-33. PubMed ID: 23633968
[TBL] [Abstract][Full Text] [Related]
13. Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility.
Gray PJ; Lin CC; Sineshaw H; Paly JJ; Jemal A; Efstathiou JA
Cancer; 2015 Mar; 121(5):681-7. PubMed ID: 25345675
[TBL] [Abstract][Full Text] [Related]
14. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
15. Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes.
Xu Z; Becerra AZ; Justiniano CF; Boodry CI; Aquina CT; Swanger AA; Temple LK; Fleming FJ
Dis Colon Rectum; 2017 Dec; 60(12):1250-1259. PubMed ID: 29112560
[TBL] [Abstract][Full Text] [Related]
16. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal.
Gilbar P; Lee A; Pokharel K
J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241
[TBL] [Abstract][Full Text] [Related]
17. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
[TBL] [Abstract][Full Text] [Related]
18. Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy.
Shea AM; Curtis LH; Hammill BG; DiMartino LD; Abernethy AP; Schulman KA
JAMA; 2008 Jul; 300(2):189-96. PubMed ID: 18612116
[TBL] [Abstract][Full Text] [Related]
19. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
